Summit Therapeutics SMMT Business Segments — Other income, net
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Summit Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:NonoperatingIncomeExpense.
The official record: Summit Therapeutics’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Summit Therapeutics's business segments — other income, net.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Summit Therapeutics's business segments — other income, net?
- Summit Therapeutics (SMMT) reported business segments — other income, net of $5.79M in Q1 2026.
- How has Summit Therapeutics's business segments — other income, net changed year-over-year?
- Summit Therapeutics's business segments — other income, net increased by 47.0% year-over-year, from $3.94M to $5.79M.
- What is the long-term trend for Summit Therapeutics's business segments — other income, net?
- Over 3 years (2022 to 2025), Summit Therapeutics's business segments — other income, net has grown at a 86.4% compound annual growth rate (CAGR), from -$2.29M to $14.84M.
- What does business segments — other income, net mean?
- Net income generated from sources other than the segment's primary business activities.
- How do you interpret business segments — other income, net?
- Higher values indicate effective cash management or non-core asset monetization, providing a buffer against operating losses.
- How does business segments — other income, net compare across companies?
- Standard 'Other Income' line item found in the non-operating section of the income statement for most firms.